These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32785665)

  • 1. Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance.
    Atchison C; Pristerà P; Cooper E; Papageorgiou V; Redd R; Piggin M; Flower B; Fontana G; Satkunarajah S; Ashrafian H; Lawrence-Jones A; Naar L; Chigwende J; Gibbard S; Riley S; Darzi A; Elliott P; Ashby D; Barclay W; Cooke GS; Ward H
    Clin Infect Dis; 2021 May; 72(9):e384-e393. PubMed ID: 32785665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers.
    Davies B; Araghi M; Moshe M; Gao H; Bennet K; Jenkins J; Atchison C; Darzi A; Ashby D; Riley S; Barclay W; Elliott P; Ward H; Cooke G
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab496. PubMed ID: 34796246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
    Moshe M; Daunt A; Flower B; Simmons B; Brown JC; Frise R; Penn R; Kugathasan R; Petersen C; Stockmann H; Ashby D; Riley S; Atchison C; Taylor GP; Satkunarajah S; Naar L; Klaber R; Badhan A; Rosadas C; Marchesin F; Fernandez N; Sureda-Vives M; Cheeseman H; O'Hara J; Shattock R; Fontana G; Pallett SJC; Rayment M; Jones R; Moore LSP; Ashrafian H; Cherapanov P; Tedder R; McClure M; Ward H; Darzi A; Elliott P; Cooke GS; Barclay WS;
    BMJ; 2021 Mar; 372():n423. PubMed ID: 33653694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.
    Flower B; Brown JC; Simmons B; Moshe M; Frise R; Penn R; Kugathasan R; Petersen C; Daunt A; Ashby D; Riley S; Atchison CJ; Taylor GP; Satkunarajah S; Naar L; Klaber R; Badhan A; Rosadas C; Khan M; Fernandez N; Sureda-Vives M; Cheeseman HM; O'Hara J; Fontana G; Pallett SJC; Rayment M; Jones R; Moore LSP; McClure MO; Cherepanov P; Tedder R; Ashrafian H; Shattock R; Ward H; Darzi A; Elliot P; Barclay WS; Cooke GS
    Thorax; 2020 Dec; 75(12):1082-1088. PubMed ID: 32796119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol.
    Riley S; Atchison C; Ashby D; Donnelly CA; Barclay W; Cooke GS; Ward H; Darzi A; Elliott P;
    Wellcome Open Res; 2020; 5():200. PubMed ID: 33997297
    [No Abstract]   [Full Text] [Related]  

  • 6. Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay.
    Atchison CJ; Moshe M; Brown JC; Whitaker M; Wong NCK; Bharath AA; McKendry RA; Darzi A; Ashby D; Donnelly CA; Riley S; Elliott P; Barclay WS; Cooke GS; Ward H
    Clin Infect Dis; 2023 Feb; 76(4):658-666. PubMed ID: 35913410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test.
    Jing M; Bond R; Robertson LJ; Moore J; Kowalczyk A; Price R; Burns W; Nesbit MA; McLaughlin J; Moore T
    Sci Rep; 2022 Jan; 12(1):1173. PubMed ID: 35064150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
    Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
    Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usability of an At-Home Anterior Nares SARS-CoV-2 RT-PCR Sample Collection Kit: Human Factors Feasibility Study.
    Strong LE; Middendorf I; Turner M; Edwards V DK; Sama V; Mou J; Adams KC
    JMIR Hum Factors; 2021 Dec; 8(4):e29234. PubMed ID: 34609947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
    Barreira GA; Santos EHD; Pereira MFB; Rodrigues KA; Rocha MC; Kanunfre KA; Marques HHS; Okay TS; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Costa Reis AGA; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
    Rev Inst Med Trop Sao Paulo; 2022; 64():e49. PubMed ID: 35858039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays.
    Mafi S; Rogez S; Darreye J; Alain S; Hantz S
    Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115900. PubMed ID: 36716586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.
    Jing M; Bond R; Robertson LJ; Moore J; Kowalczyk A; Price R; Burns W; Nesbit MA; McLaughlin J; Moore T
    Sci Rep; 2021 Jul; 11(1):14026. PubMed ID: 34234188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort Study.
    Herbert C; Broach J; Heetderks W; Qashu F; Gibson L; Pretz C; Woods K; Kheterpal V; Suvarna T; Nowak C; Lazar P; Ayturk D; Barton B; Achenbach C; Murphy R; McManus D; Soni A
    JMIR Form Res; 2022 Oct; 6(10):e35426. PubMed ID: 36041004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test.
    Zhang Y; Chen Y; He Y; Li Y; Zhang X; Liang J; He J; Lu S; Gao Z; Xu J; Tang Y
    Talanta; 2023 Apr; 255():124200. PubMed ID: 36565525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.